PRESS RELEASE published on 05/28/2026 at 07:30, 3 months 24 days ago BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance BRAIN Biotech AG reports half-year figures for fiscal year 2025/26, with sequential growth in core segment BRAINBiocatalysts and a new European patent for genome editing. Full year guidance confirmed Financial Forecast Half-year Results BRAIN Biotech AG EU Patent Genome Editing
BRIEF published on 03/23/2026 at 11:10, 5 months 29 days ago BRAIN Biotech obtient un brevet pour la technologie CRISPR-BMC BRAIN Biotech Édition Du Génome Brevet Accordé CRISPR-BMC Potentiel De Licences
BRIEF published on 03/23/2026 at 11:10, 5 months 29 days ago BRAIN Biotech Secures Patent for CRISPR-BMC Technology BRAIN Biotech Genome-editing CRISPR-BMC Patent Granted Licensing Potential
PRESS RELEASE published on 03/23/2026 at 11:05, 5 months 29 days ago BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology BRAIN Biotech secures key patent for CRISPR-BMC genome-editing technology, opening potential for commercial use through licensing. Nuclease exhibits high activity in various organisms Patent BRAIN Biotech Licensing CRISPR-BMC Genome-editing Technology
BRIEF published on 03/11/2026 at 17:10, 6 months 10 days ago BRAIN Biotech AG 2026 AGM Results Annual General Meeting Supervisory Board BRAINBiocatalysts Two-pillar Strategy Enzyme Production
BRIEF published on 03/11/2026 at 17:10, 6 months 10 days ago Résultats de l'assemblée générale annuelle 2026 de BRAIN Biotech AG Conseil De Surveillance Assemblée Générale Annuelle Stratégie À Deux Piliers Biocatalyseurs CÉRÉBRAUX Production D'enzymes
PRESS RELEASE published on 03/11/2026 at 17:05, 6 months 10 days ago Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG. Shareholders approve all agenda items. New member elected to the Supervisory Board. CEO highlights company's strategy and unique selling points Annual General Meeting Financial Year Supervisory Board BRAIN Biotech AG Product Innovations
BRIEF published on 02/25/2026 at 07:35, 6 months 24 days ago BRAIN Biotech Reports Q1 Results and SolasCure's Clinical Milestone Financial Performance BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel
BRIEF published on 02/25/2026 at 07:35, 6 months 24 days ago BRAIN Biotech publie ses résultats du premier trimestre et SolasCure franchit une étape clinique importante Performance Financière BRAIN Biotech Résultats Du Premier Trimestre SolasCure Gel Pour Plaies Aurase
PRESS RELEASE published on 02/25/2026 at 07:30, 6 months 24 days ago BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds BRAIN Biotech's Q1 25/26 results show revenue decline but improved EBITDA. Breakthrough Aurase Wound Gel by SolasCure for chronic wounds. BRAIN BioIncubator segment thrives EBITDA BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel
Published on 09/22/2026 at 00:00, 2 hours 52 minutes ago Alset AI Announces Shares for Debt Transaction
Published on 09/21/2026 at 15:45, 11 hours 7 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 12 hours 32 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 12 hours 47 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 12 hours 52 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/22/2026 at 01:05, 1 hour 46 minutes ago ESENTIA Announces the Execution of an Agreement to Acquire the Guadalajara-Manzanillo Natural Gas Pipeline System, Connecting Existing System to the Port of Manzanillo
Published on 09/21/2026 at 22:05, 4 hours 47 minutes ago Abivax Presents Business Updates and First Half 2026 Financial Results
Published on 09/21/2026 at 22:05, 4 hours 47 minutes ago Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026
Published on 09/21/2026 at 20:34, 6 hours 17 minutes ago BRANICKS Group AG: Regular interest payment on EUR 400 million bond to be made as scheduled – Completion of maturity extension imminent
Published on 09/21/2026 at 19:00, 7 hours 52 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 14 septembre 2026 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 8 hours 33 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 8 hours 33 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 8 hours 50 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 9 hours 6 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 9 hours 6 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026